Seeing Is Believing

Currently out of the existing stock ratings of Matthew Harrison, 396 are a HOLD (36.16%), 617 are a BUY (56.35%), 82 are a SELL (7.49%).
Analyst Matthew Harrison, currently employed at SUSQUEHANNA, carries an average stock price target met ratio of 62.72% that have a potential upside of 31.38% achieved within 316 days. Previously, Matthew Harrison worked at MORGAN STANLEY.
Matthew Harrison’s has documented 2,143 price targets and ratings displayed on 103 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy, Industrials, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on R, Ryder System.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Mar-2024
$5
$3.87 (342.48%)
$10
1 months 16 days ago
(17-Aug-2026)
0/5 (0%)
$3.9 (354.55%)
Buy Since 29-Oct-2020
$8
3 months 25 days ago
(08-Jun-2026)
0/16 (0%)
$4.24 (112.77%)
Buy Since 05-May-2026
$2
$0.87 (76.99%)
$6
3 months 29 days ago
(04-Jun-2026)
0/3 (0%)
$0.68 (51.52%)
Buy Since 10-May-2022
$5
$3.98 (390.20%)
$8
1 years 3 months 13 days ago
(20-Jun-2025)
0/13 (0%)
$2.23 (80.51%)
Buy Since 08-Nov-2024
$8
$6.98 (684.31%)
$6
1 years 7 months 9 days ago
(24-Feb-2025)
0/2 (0%)
$6.4 (400.00%)
Which stock is Matthew Harrison most bullish on?
Which stock is Matthew Harrison most reserved on?
What Year was the first public recommendation made by Matthew Harrison?